New in-house flow cytometry service
October 8, 2025

We are thrilled to announce that Pharmidex now offers an in-house flow cytometry service powered by the Attune™ NxT Acoustic Flow Cytometer + CytKick Max Autosampler, combining precision, throughput and cutting-edge capability.

With this platform, we can deliver a wide array of flow cytometry assays:


• High-dimensional immunophenotyping (T cells, B cells, NK, myeloid, ILCs)
• Viability/apoptosis, mitochondrial health, ROS and cell cycle analyses
• Functional assays: cytokine staining, proliferation, degranulation
• High-throughput screening (96/384-well plates) for drug candidates
• Rare-event detection (CTCs, minimal residual disease)
• Kinetic assays (calcium flux, uptake, time-course studies)


Pharmidex will integrate this new capability with our existing services:


• Histology & imaging: correlate cell subsets with tissue architecture
• Biomarker analysis: cross-validate flow-based biomarker readouts with proteomics, ELISA and transcriptomics
• In vivo & disease models: combine flow readouts from tissues/fluids with in vivo pharmacology, toxicology and PK/PD
• Autoimmune & immuno-oncology studies: dissect immune cell phenotypes, function and kinetics in preclinical models


If you’re interested in using flow cytometry in your next study or discussing how it can enhance your current project with Pharmidex’s broader service portfolio, I’d love to hear from you.

🔗 Learn more about our full services: (https://lnkd.in/eAdhrhFp) (https://lnkd.in/e9uXhXiB)

Flow Cytometry
Flow Cytometry
Flow Cytometry

#FlowCytometry #AttuneNxT #DrugDiscovery #Pharmidex #Immunology

🍩 Donut Day at Pharmidex!

February 24, 2026
Today we took a short pause from the science to enjoy some well-deserved donuts together in the office. At Pharmidex , we believe culture matters just as much as capability. Moments like this simple, informal, and inclusive are part of what keeps our team connected and motivated. As a preclinical CRO, we support over 400 clients each year from our UK laboratories, delivering high-quality in vivo and bioanalytical services to advance drug discovery programmes.  A small break. A strong team. Back to delivering great science. If we can support your next drug discovery project, do get in touch.

CNS preclinical services

February 23, 2026
🧠 Did you know that Pharmidex offers specialist CNS preclinical services to accelerate neuroscience drug discovery? At Pharmidex, we provide expert in vivo and ex vivo neurochemistry and neurobehavioural capabilities to support the progression of CNS drug candidates across key readouts including PK, PD, target engagement and efficacy. Our CNS platform is designed to help you address the complex challenges of developing therapies for neurodegenerative and psychiatric disorders such as Alzheimer’s, Parkinson’s, schizophrenia and depression. From microdialysis and brain bioanalysis to blood–brain barrier assessment and sophisticated neurobehavioural models, we deliver actionable data to guide confident decision-making in your neuroscience programmes. Learn more about how Pharmidex can support your CNS research: 🔗 www.pharmidex.com/CNS

🥞 Pancake Day at Pharmidex

February 19, 2026
Science is serious… but Pancake Day is not. Yesterday we took a short pause from studies, data and reports to enjoy some well-earned pancakes together as a team. With Ramadan also beginning, we made sure there were plenty saved for colleagues breaking their fast later in the evening. At Pharmidex , we’re proud of the work we deliver, but we’re equally proud of the people behind it. Small moments like this remind us that strong teams are built not only in the lab, but around the table too. Thank you to everyone for your hard work and for making our culture what it is. 🙌
More Posts